PursueCare Launches RESET® and RESET-O® Digital Solutions
PursueCare, a pioneer in virtual addiction treatment, has introduced RESET® and RESET-O®, forming a crucial part of the landscape of digital therapeutics for addiction. These innovative solutions hold the distinction of being the first FDA-authorized prescription digital therapeutics (PDTs) aimed specifically at treating substance use disorder (SUD) and opioid use disorder (OUD). What’s truly remarkable is how these app-based therapies are designed to empower users through a self-directed 12-week cognitive behavioral therapy (CBT) regimen. By encouraging patients to complete sessions and adhere to treatment protocols, these tools aim to decrease drug use, maintain user engagement, and lower overall healthcare expenditures.
Purpose and Development of RESET® and RESET-O®
Originally, RESET® and RESET-O® were developed and launched by Pear Therapeutics, Inc. PursueCare acquired these valuable digital tools, enhancing their portfolio of virtual treatment options. The integration of these PDTs into PursueCare’s comprehensive treatment framework aims to establish value-based care partnerships with health insurers. Furthermore, PursueCare is collaborating with clinical partners to facilitate wider access to RESET® and RESET-O® for patients in need.
Real-World Advantages and Savings
RESET® and RESET-O® are tailored to complement outpatient care, including medications for opioid use disorder (MOUD). They promote ongoing support and personalized tracking of patient achievements. By improving patient interaction and commitment, these therapies align seamlessly with the preferred value-based care strategies advocated by various health plans. Data from experts further illustrates the tangible benefits of these treatments. Users of RESET® and RESET-O® have reportedly saved Massachusetts over $2,011 per user in healthcare-related expenses, with reductions in emergency visits and hospitalizations by 45% and 64%, respectively.
“At PursueCare, we are dedicated to making high-quality care accessible,” said Nick Mercadante, the Founder and Chief Executive Officer of PursueCare. He elaborated on how RESET® and RESET-O® resonate with their core mission, claiming that these digital therapies empower individuals to take charge of their health, while establishing a new benchmark for chronic substance use disorder care.
Comprehensive Care through Digital Solutions
PursueCare employs a multifaceted virtual clinic model that offers healthcare services for addiction to opioids, alcohol, stimulants, and other substances through an experienced team of professionals. The treatment plans provided include MOUD, which is sometimes referred to as medication-assisted treatment, alongside counseling, psychiatry, and targeted case management. They also cater to addressing common physical health concerns associated with substance abuse. Patients can rely on PursueCare’s smartphone app for effective management of their recovery, ensuring clinicians can be accessible whenever necessary. Dr. Jason Kirby, DO, MBA, FASAM, and PursueCare’s Medical Director, noted, “RESET® and RESET-O® are crucial for keeping patients engaged, while the insights gleaned from the data allow us to provide personalized, effective care.”
Expanding Access to Addiction Care
PursueCare is committed to improving availability to addiction treatment by forging partnerships with health systems and local community providers. Integrating screening and referrals at pivotal junctures, like emergency departments, enables timely intervention for individuals, allowing for immediate initiation of treatment. Insights from recent studies sponsored by the National Institute on Drug Abuse (NIDA) highlight the importance of adopting a coordinated, multidisciplinary methodology to enhance patient outcomes.
About PursueCare
PursueCare is devoted to delivering customized virtual addiction treatment across several states. The mission of this innovative company is centered around enhancing access to sustained care via telehealth services. Patients work with a diverse team that offers medical, psychiatric, and pharmacy services tailored to their individual needs. The FDA-authorized digital therapies, RESET® and RESET-O®, are instrumental in supporting recovery efforts around the clock. PursueCare proudly accepts various forms of payment, including private insurance, Medicare, and Medicaid.
Frequently Asked Questions
What are RESET® and RESET-O®?
RESET® and RESET-O® are FDA-authorized prescription digital therapeutics aimed at treating substance and opioid use disorders through cognitive behavioral therapy.
How do these digital therapeutics work?
They provide a self-guided, 12-week CBT course that encourages patients to complete lessons and adhere to treatment.
What type of savings have been reported from using RESET® and RESET-O®?
Patients using these services saved over $2,011 in healthcare costs, along with significant reductions in hospitalizations and emergency visits.
Who developed RESET® and RESET-O®?
The original development was undertaken by Pear Therapeutics, Inc., which was later acquired by PursueCare.
How does PursueCare aim to utilize these therapeutics?
PursueCare intends to integrate these PDTs within its broader virtual care offerings and establish partnerships for expanded patient access.
